Screener
NeoGenomics NEO Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $209.25M+11.4% | $201.66M+11.2% | $186.67M+11.1% | $190.17M+10.6% | $187.8M+11.9% | ||
| $112.67M+5.0% | $109.78M+5.5% | $105.81M+11.6% | $106.83M+12.8% | $107.35M+15.5% | ||
| $96.59M+20.1% | $91.88M+18.9% | $80.86M+10.4% | $83.34M+7.9% | $80.45M+7.4% | ||
| 46.2%+3.3pp | 45.6%+3.0pp | 43.3%-0.3pp | 43.8%-1.1pp | 42.8%-1.8pp | ||
| $9.86M+13.4% | $10.76M+19.3% | $9.53M-6.4% | $9.18M+15.2% | $8.69M+13.1% | ||
| $27.6M+26.6% | $27.28M+13.3% | $23.83M+5.1% | $23.44M+4.9% | $21.81M+6.8% | ||
| $67.07M-4.0% | $63.61M-11.3% | $65.74M-3.6% | $63.51M-0.2% | $69.87M+4.3% | ||
| $104.53M-2.7% | $101.65M-18.6% | $99.11M-1.9% | $96.76M+1.1% | $107.46M+11.8% | ||
| -$7.94M+70.6% | -$9.77M+79.5% | -$18.24M+34.4% | -$13.41M+27.1% | -$27.01M-27.4% | ||
| -3.8%+10.6pp | -4.8%+21.4pp | -9.8%+6.8pp | -7.1%+3.6pp | -14.4%-1.8pp | ||
| $1.27M+110% | $781K-16.3% | $598K-63.0% | $599K-63.1% | $603K-63.3% | ||
| -$9K+97.3% | -$17K-104% | -$12K-118% | $84K+119% | -$335K-206% | ||
| -$8.02M+69.6% | $1.83M+104% | -$17.58M+31.5% | -$12.41M+23.1% | -$26.39M-47.8% | ||
| -$475K-164% | -$412K+43.1% | -$472K-277% | -$2.53M-214% | $740K+593% | ||
| -$7.55M+72.2% | $2.24M+105% | -$17.11M+34.0% | -$9.88M+35.5% | -$27.13M-53.3% | ||
| -3.6%+10.8pp | 1.1%+26.0pp | -9.2%+6.3pp | -5.2%+3.7pp | -14.4%-3.9pp | ||
| $5.23M+149% | $3.42M+111% | -$1.83M+81.9% | $2.98M+1,500% | -$10.58M-229% | ||
| 2.5%+8.1pp | 1.7%+18.4pp | -1%+5.0pp | 1.6%+1.7pp | -5.6%-3.7pp | ||
| -$7.94M+70.6% | -$9.77M+79.5% | -$18.24M+34.4% | -$13.41M+27.1% | -$27.01M-27.4% |
FAQ
- What is NeoGenomics's revenue?
- NeoGenomics (NEO) generated $787.8M in revenue over the trailing twelve months, up 11.1% year over year.
- Is NeoGenomics profitable?
- NeoGenomics is not currently profitable: it reported a net loss of $32.3M over the trailing twelve months, a -4.1% net margin.
- What are NeoGenomics's profit margins?
- Gross margin is 44.8% and operating margin is -6.3%, with a -4.1% net margin.
- What is NeoGenomics's earnings per share?
- NeoGenomics's diluted EPS over the trailing twelve months is $-0.24.
- Where does NeoGenomics's income statement data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
